Your browser doesn't support javascript.
loading
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1.
Teh, T-C; Nguyen, N-Y; Moujalled, D M; Segal, D; Pomilio, G; Rijal, S; Jabbour, A; Cummins, K; Lackovic, K; Blombery, P; Thompson, E; Ekert, P G; Lessene, G; Glaser, S P; Huang, D C S; Roberts, A W; Guthridge, M A; Wei, A H.
  • Teh TC; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
  • Nguyen NY; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Moujalled DM; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
  • Segal D; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
  • Pomilio G; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.
  • Rijal S; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia.
  • Jabbour A; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
  • Cummins K; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
  • Lackovic K; Australian Centre for Blood Diseases, Monash University, Alfred Medical Research and Education Precinct, Melbourne, Victoria, Australia.
  • Blombery P; Department of Clinical Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.
  • Thompson E; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.
  • Ekert PG; Departments of Medicine and Medical Biology, Faculty of Medicine, University of Melbourne, Parkville, Victoria. Australia.
  • Lessene G; Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Glaser SP; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  • Huang DCS; Victorian Comprehensive Cancer Centre, Parkville, Victoria, Australia.
  • Roberts AW; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  • Guthridge MA; Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
  • Wei AH; Walter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.
Leukemia ; 32(2): 303-312, 2018 02.
Article en En | MEDLINE | ID: mdl-28751770
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteína 1 de la Secuencia de Leucemia de Células Mieloides Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Compuestos Bicíclicos Heterocíclicos con Puentes / Proteína 1 de la Secuencia de Leucemia de Células Mieloides Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article